Harbour Investments’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45M Sell
50,629
-8,182
-14% -$260K 0.02% 662
2026
Q1
$1.85M Sell
58,811
-11,448
-16% -$361K 0.03% 522
2025
Q4
$2.07M Buy
70,259
+69,735
+13,308% +$1.94M 0.04% 383
2025
Q3
$13.2K Buy
524
+441
+531% +$10.7K ﹤0.01% 2545
2025
Q2
$1.99K Buy
+83
New +$1.92K ﹤0.01% 3134
2024
Q2
Sell
-117
Closed -$3.53K 3361
2024
Q1
$3.53K Sell
117
-128
-52% -$3.55K ﹤0.01% 2614
2023
Q4
$7.01K Buy
245
+85
+53% +$2.5K ﹤0.01% 2289
2023
Q3
$5.93K Sell
160
-27
-14% -$1.03K ﹤0.01% 2217
2023
Q2
$7.29K Buy
187
+161
+619% +$6.31K ﹤0.01% 2168
2023
Q1
$949 Buy
26
+1
+4% +$32 ﹤0.01% 2697
2022
Q4
$770 Buy
+25
New +$776 ﹤0.01% 2733

Other funds holding RTO

Harbour Investments's RTO Position: Q2 2026 in Review

Harbour Investments reduced its Rentokil (RTO) stake by 14% in Q2 2026, selling an estimated $260K and leaving 50,629 shares worth $1.45M. The position accounts for 0.02% of the portfolio, ranked #662.

Harbour Investments first reported a position in RTO in Q4 2022 and has held it in 11 quarters since. The position peaked at $2.07M in Q4 2025. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Harbour Investments held 50,629 shares of Rentokil worth $1.45M as of Q2 2026.
  • Harbour Investments sold 8,182 Rentokil shares in Q2 2026, an estimated $260K.
  • Rentokil made up 0.02% of Harbour Investments's portfolio in Q2 2026, its #662 holding.
  • Harbour Investments first reported a position in Rentokil in Q4 2022 and has held it in 11 quarters since.
  • Harbour Investments's Rentokil position peaked at $2.07M in Q4 2025.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.